Hoth Therapeutics Inc
HOTH
查看詳細走勢圖
1.090USD
+0.020+1.87%
收盤 12/19, 16:00（美東）報價延遲15分鐘
16.49M總市值
虧損本益比TTM
盤中分時
1分
30分
1小時
日k
週k
月k
日k
今天
+1.87%
5天
-6.84%
1月
+5.83%
6月
-9.92%
今年開始到現在
+45.70%
1年
+34.57%
查看詳細走勢圖
TradingKey Hoth Therapeutics Inc股票評分
單位: USD 更新時間: 2025-10-27操作建議
當前估值低估，機構持股佔比非常高，近一個月多位分析師給出公司評級為買入。最高目標價max_target_price。目前股價在壓力位和支撐位之間，可以做區間波段操作。
Hoth Therapeutics Inc評分
壓力支撐
由於公司未披露，未能獲取相關數據
多維評測
本期評分
上期評分
分析師目標
基於
1
分析師
買入
評級
4.500
目標均價
+287.93%
漲幅空間
數據免責聲明：分析師評級與目標價由LSEG提供，僅供參考，不應當作投資建議
Hoth Therapeutics Inc亮點
亮點風險
Hoth Therapeutics, Inc. is a clinical-stage biopharmaceutical company focused on developing new generation therapies for unmet medical needs. The Company is focused on developing a topical formulation for treating side effects from drugs used for the treatment of cancer (HT-001); a treatment for mast-cell derived cancers and anaphylaxis (HT-KIT), and a treatment and/or prevention for Alzheimer's or other neuroinflammatory diseases (HT-ALZ). The Company also has assets being developed for atopic dermatitis (also known as eczema) (BioLexa); a treatment for asthma and allergies using inhalational administration (HT-004), and a treatment for obesity, and obesity-related diseases and conditions (HT-VA).
Hoth Therapeutics Inc新聞
即將為您帶來更多新聞，敬請期待。 。 。
財務指標
每股收益
由於公司未披露，未能獲取相關數據
營業總收入
由於公司未披露，未能獲取相關數據
Hoth Therapeutics Inc簡介
Hoth Therapeutics, Inc. is a clinical-stage biopharmaceutical company focused on developing new generation therapies for unmet medical needs. The Company is focused on developing a topical formulation for treating side effects from drugs used for the treatment of cancer (HT-001); a treatment for mast-cell derived cancers and anaphylaxis (HT-KIT), and a treatment and/or prevention for Alzheimer's or other neuroinflammatory diseases (HT-ALZ). The Company also has assets being developed for atopic dermatitis (also known as eczema) (BioLexa); a treatment for asthma and allergies using inhalational administration (HT-004), and a treatment for obesity, and obesity-related diseases and conditions (HT-VA).
公司代碼HOTH
公司Hoth Therapeutics Inc
CEOKnie (Robb)
網址https://hoththerapeutics.com/
常見問題
Hoth Therapeutics Inc(HOTH)的當前股價是多少？
Hoth Therapeutics Inc(HOTH)的當前股價是 1.090。
Hoth Therapeutics Inc 的股票代碼是什麼？
Hoth Therapeutics Inc的股票代碼是HOTH。
Hoth Therapeutics Inc股票的52週最高點是多少？
Hoth Therapeutics Inc股票的52週最高點是3.800。
Hoth Therapeutics Inc股票的52週最低點是多少？
Hoth Therapeutics Inc股票的52週最低點是0.655。
Hoth Therapeutics Inc的市值是多少？
Hoth Therapeutics Inc的市值是16.49M。
Hoth Therapeutics Inc的淨利潤是多少？
Hoth Therapeutics Inc的淨利潤為-8.19M。
現在Hoth Therapeutics Inc(HOTH)的股票是買入、持有還是賣出？
根據分析師評級，Hoth Therapeutics Inc(HOTH)的總體評級為買入，目標價格為4.500。
Hoth Therapeutics Inc(HOTH)股票的每股收益（EPS TTM）是多少
Hoth Therapeutics Inc(HOTH)股票的每股收益（EPS TTM）是-1.022。
相關品種
+1.32%
-0.88%
+1.75%
+0.83%
+0.60%
+0.38%
+0.91%
+1.03%
+2.32%
+0.60%
+0.40%
+1.97%
+1.63%
+1.21%
+0.65%
+0.66%
+2.57%
0.00%
-0.44%
+1.06%
